UC Comprehensive Cancer Center at Silver Cross — New Lenox, Illinois

Public research footprint of UC Comprehensive Cancer Center at Silver Cross, compiled from the ClinicalTrials.gov public registry.

183

Registered studies

131

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Endometrial Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Endometrial Clear Cell Adenocarcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)
NCT06589804 — Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UC Comprehensive Cancer Center at Silver Cross?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.